Afam Capital Has Lowered Its Sanofi (SNY) Position; Meru Capital Group LP Trimmed Its Interxion Holding N.V (INXN) Position

July 13, 2017 - By Linda Rogers

Afam Capital Inc decreased Sanofi (SNY) stake by 22.24% reported in 2016Q4 SEC filing. Afam Capital Inc sold 26,707 shares as Sanofi (SNY)’s stock rose 14.25%. The Afam Capital Inc holds 93,371 shares with $3.78M value, down from 120,078 last quarter. Sanofi now has $126.30B valuation. The stock declined 0.61% or $0.3 reaching $48.59 per share. About 980,130 shares traded. Sanofi SA (ADR) (NYSE:SNY) has risen 26.96% since July 13, 2016 and is uptrending. It has outperformed by 10.26% the S&P500.

Meru Capital Group Lp decreased Interxion Holding N.V (INXN) stake by 21.49% reported in 2016Q4 SEC filing. Meru Capital Group Lp sold 34,213 shares as Interxion Holding N.V (INXN)’s stock rose 15.41%. The Meru Capital Group Lp holds 125,000 shares with $4.38M value, down from 159,213 last quarter. Interxion Holding N.V now has $3.26 billion valuation. The stock declined 0.20% or $0.09 reaching $45.79 per share. About 180,645 shares traded. InterXion Holding NV (NYSE:INXN) has risen 30.50% since July 13, 2016 and is uptrending. It has outperformed by 13.80% the S&P500.

Meru Capital Group Lp increased Advance Auto Parts Inc (NYSE:AAP) stake by 54,172 shares to 62,172 valued at $10.52M in 2016Q4. It also upped Facebook Inc (NASDAQ:FB) stake by 70,972 shares and now owns 214,673 shares. Symantec Corp (NASDAQ:SYMC) was raised too.

Analysts await InterXion Holding NV (NYSE:INXN) to report earnings on August, 2. They expect $0.17 EPS, up 13.33% or $0.02 from last year’s $0.15 per share. INXN’s profit will be $12.10M for 67.34 P/E if the $0.17 EPS becomes a reality. After $0.16 actual EPS reported by InterXion Holding NV for the previous quarter, Wall Street now forecasts 6.25% EPS growth.

Among 10 analysts covering Interxion Holding NV (NYSE:INXN), 7 have Buy rating, 0 Sell and 3 Hold. Therefore 70% are positive. Interxion Holding NV had 17 analyst reports since August 6, 2015 according to SRatingsIntel. On Tuesday, May 23 the stock rating was maintained by RBC Capital Markets with “Outperform”. The firm has “Buy” rating given on Thursday, November 5 by Canaccord Genuity. On Wednesday, July 5 the stock rating was maintained by RBC Capital Markets with “Buy”. The firm has “Buy” rating by RBC Capital Markets given on Monday, April 24. Jefferies maintained InterXion Holding NV (NYSE:INXN) rating on Friday, June 9. Jefferies has “Hold” rating and $3600 target. The rating was upgraded by Citigroup to “Buy” on Thursday, November 5. As per Wednesday, June 1, the company rating was upgraded by Wells Fargo. Barclays Capital initiated the shares of INXN in report on Monday, September 28 with “Overweight” rating. The stock of InterXion Holding NV (NYSE:INXN) earned “Buy” rating by Stifel Nicolaus on Wednesday, April 26. The stock has “Buy” rating by Evercore on Monday, October 26.

Analysts await Sanofi SA (ADR) (NYSE:SNY) to report earnings on August, 4. They expect $0.78 earnings per share, up 5.41% or $0.04 from last year’s $0.74 per share. SNY’s profit will be $2.03 billion for 15.57 P/E if the $0.78 EPS becomes a reality. After $0.76 actual earnings per share reported by Sanofi SA (ADR) for the previous quarter, Wall Street now forecasts 2.63% EPS growth.

Afam Capital Inc increased Ishares Msci Brazil Capped Index Fund (EWZ) stake by 70,752 shares to 125,083 valued at $4.17M in 2016Q4. It also upped Health Care Select Sector Spdr (XLV) stake by 4,878 shares and now owns 61,525 shares. Ishares Msci Thailand Capped Etf (THD) was raised too.

Among 10 analysts covering Sanofi-aventis Sa (NYSE:SNY), 3 have Buy rating, 1 Sell and 6 Hold. Therefore 30% are positive. Sanofi-aventis Sa had 16 analyst reports since October 15, 2015 according to SRatingsIntel. As per Friday, April 21, the company rating was maintained by JP Morgan. Goldman Sachs initiated Sanofi SA (ADR) (NYSE:SNY) on Monday, November 7 with “Neutral” rating. On Friday, September 23 the stock rating was initiated by Piper Jaffray with “Neutral”. The stock of Sanofi SA (ADR) (NYSE:SNY) has “Hold” rating given on Tuesday, May 3 by HSBC. Bernstein downgraded Sanofi SA (ADR) (NYSE:SNY) on Monday, November 9 to “Mkt Perform” rating. The rating was downgraded by BNP Paribas on Thursday, December 10 to “Underperform”. The firm earned “Buy” rating on Thursday, September 8 by Berenberg. The firm has “Overweight” rating by Morgan Stanley given on Thursday, October 15. The stock has “Sell” rating by JP Morgan on Friday, March 31. As per Thursday, May 12, the company rating was upgraded by Barclays Capital.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.